ARIONIX LABORATORIES  ·  PRESCRIPTION ONLY

Protocol-Driven
Dermatology

Building India's most trusted prescription-only dermatology brand — one clinical protocol at a time.

SCROLL
01

Prescription Only

Every Arionix product is formulated exclusively for prescription use. We do not operate in the OTC channel. Your patients receive what only a dermatologist can prescribe.

02

Dermatologist Endorsed

Our product protocols are designed in consultation with practising dermatologists. We build products around real clinical scenarios, not retail demand.

03

Science-Backed

Each formulation is built on peer-reviewed evidence. Actives are chosen for clinical efficacy, optimal concentration, and demonstrated patient tolerance.

WHO WE ARE

Built for the Prescription Channel. Only.

Arionix Laboratories is a prescription-only dermatology pharmaceutical company committed to elevating the standard of dermatological treatment in India.

Operating under Aradhana Pharmaceuticals, headquartered in Gurugram, Haryana, every product we create has one purpose — to give dermatologists a brand they can trust completely.

100%
PRESCRIPTION CHANNEL ONLY
WHO-GMP
CERTIFIED MANUFACTURING
Pan India
VISION & REACH
Protocol
DRIVEN PRODUCT ARCHITECTURE
OUR MISSION

To Establish Protocol-Driven
Dermatology Across India

We do not launch products for the sake of portfolio size. Every SKU we launch has a defined clinical role, a defined patient profile, and a defined position in a dermatologist's treatment sequence.

OUR PHILOSOPHY

Three Principles.
Non-Negotiable.

I

Clinical Protocols First

Before any product is developed, we map the clinical protocol it belongs to. Each product is a piece of a larger treatment system — not a standalone SKU.

II

Prescription Integrity

Arionix products are never sold over the counter. We protect the dermatologist's authority and the patient's safety. We will never compromise this position.

III

Formulation Honesty

Each active is chosen for proven clinical efficacy, appropriate concentration, and demonstrated patient tolerance. We follow the science, not the trend.

MANUFACTURING

WHO-GMP Certified.
Every Batch. Every Time.

All Arionix products are manufactured at WHO-GMP certified pharmaceutical plants, meeting the highest standards of quality, safety, and regulatory compliance. Our manufacturing partners are fully compliant with Schedule M requirements under the Drugs and Cosmetics Act.

✓  WHO-GMP Certified
✓  Schedule M Compliant
✓  Drugs & Cosmetics Act
OUR COMPANY

Arionix Laboratories

A Division of Aradhana Pharmaceuticals

The Roselia, 06 GF, Sector 95A
Gurugram — 122505, Haryana, India

info@arionixlabs.com
+91-7985759455
www.arionixlabs.com

OUR PORTFOLIO

Our Products

Carefully formulated. Clinically mapped. Made for prescription practice.

Barrionix-BFM Barrier Repair Cream
Barrier Repair & Moisturising Cream

Barrionix-BFM

Restore. Protect. Rebuild.
Key Actives
Ceramide Complex Hyaluronic Acid Polyglutamic Acid Rice Bran Extract Plant Oils
Indicated For

Compromised, dry & sensitive skin. Atopic dermatitis, eczema, steroid-damaged skin, and post-procedure barrier support.

50 g
Prescription Only
WHO-GMP Certified
Salnix-F Foaming Face Wash
Foaming Face Wash

Salnix-F

Cleanse. Clarify. Balance.
Key Actives
2% Salicylic Acid Moringa Extract D-Panthenol
Indicated For

Suitable for all skin types. Gently removes excess oil and impurities, helps unclog pores, reduces breakouts, and maintains skin balance and hydration.

100 ml
Prescription Only
WHO-GMP Certified
FOR DERMATOLOGISTS

Built Around
How You Think

In protocols. In sequences. In clinical outcomes. Not in SKUs.

WHY PRESCRIBE ARIONIX

Four Reasons Dermatologists
Trust Arionix

01

Protocol-First Architecture

Every Arionix SKU is mapped to a specific position in a clinical protocol. Products are designed to work together as a coherent treatment system — not as isolated brands competing for the same prescription.

02

Prescription-Only Commitment

Arionix products are never available over the counter. Your prescription carries clinical authority. We protect that authority by ensuring our products can only reach patients through you.

03

Formulation Transparency

Our product literature clearly states every active, its concentration, its mechanism, and its clinical evidence base. If a formulation cannot be justified clinically, it does not get launched.

04

WHO-GMP Manufacturing

All products are manufactured at WHO-GMP and Schedule M compliant facilities, ensuring the batch your patient receives meets the same standard every time.

CLINICAL PROTOCOL

Barrier Repair Protocol

Barrier Repair — Two Step System

1
Cleanser — Salnix-F Foaming Face Wash
Gentle daily cleansing. Maintains skin pH balance. Removes excess sebum without stripping the barrier. 2% Salicylic Acid for pore clarification.
2
Barrier Repair — Barrionix-BFM Cream
Twice daily application. Replenishes ceramides, restores lipid matrix, reduces transepidermal water loss. Suitable for post-procedure and atopic skin.
Goal: Restore compromised skin barrier, reduce transepidermal water loss, improve patient comfort and treatment tolerance across all skin types.

For Product Literature & Enquiries

info@arionixlabs.com  ·  +91-7985759455

SCIENCE & INSIGHTS

Clinical
Perspectives

Evidence-based insights for dermatology practice.

BARRIER REPAIR

Skin Barrier Repair: The Missing Step in Dermatology Treatment Plans

Skin barrier dysfunction underlies atopic dermatitis, eczema, steroid-damaged skin, and poor treatment tolerance. Here is why barrier repair should be routine in every treatment plan.

READ ARTICLE →
CLEANSING SCIENCE

The Role of the Cleanser in Dermatology Practice

The cleanser is the most underestimated product in a dermatology protocol. Here is why the right face wash matters significantly for treatment outcomes.

READ ARTICLE →
MELASMA

Melasma in Indian Skin: Why Standard Protocols Fail

Melasma is the most mismanaged condition in Indian dermatology. Here is why standard approaches fall short and what a complete protocol looks like.

READ ARTICLE →
PHOTOPROTECTION

Why Sunscreen Compliance Fails in Indian Patients

The biggest reason melasma and PIH relapse is sunscreen non-compliance. Here is the clinical evidence and how dermatologists can improve patient adherence.

READ ARTICLE →
← Back to Articles
BARRIER REPAIR

Skin Barrier Repair: The Missing Step in Dermatology Treatment Plans

The skin barrier — the stratum corneum and its lipid matrix of ceramides, fatty acids, and cholesterol — is the first line of defence against environmental triggers, allergens, and transepidermal water loss. When this barrier is compromised, everything else in the treatment plan becomes harder to achieve.

Barrier dysfunction is central to atopic dermatitis, but it is also a clinically significant issue in patients on prolonged topical steroid therapy, those undergoing chemical peels or laser procedures, patients with chronic eczema, and those with naturally dry or sensitive skin types.

Ceramides are the primary lipid component of the skin barrier and are significantly reduced in atopic skin. Supplementing barrier lipids through a ceramide-based moisturiser is an evidence-based intervention that reduces flare frequency, improves patient comfort, and allows other active treatments to work more effectively.

Niacinamide and Polyglutamic Acid complement ceramide supplementation by stimulating endogenous ceramide synthesis, reducing transepidermal water loss, and supporting the skin's natural hydration mechanisms.

Barrier repair should not be an afterthought in a treatment plan. For patients with atopic dermatitis, post-procedure skin, or any condition involving barrier compromise, a dedicated barrier repair moisturiser is as important as the active treatment prescribed alongside it.

← Back to Articles
CLEANSING SCIENCE

The Role of the Cleanser in Dermatology Practice

The cleanser is often the first product a dermatology patient uses every day, yet it is frequently the last thing discussed in a consultation. This is a missed clinical opportunity. The wrong cleanser — too harsh, too stripping, or with inappropriate actives — can undermine an otherwise well-designed treatment plan.

For patients with acne-prone or oily skin, a salicylic acid-based foaming cleanser offers several clinical advantages. Salicylic acid is a beta-hydroxy acid that is lipophilic, allowing it to penetrate into sebaceous follicles and dissolve the comedonal plug that initiates acne formation.

The choice of cleanser also directly impacts skin barrier health. Overly alkaline cleansers disrupt the skin's natural acid mantle, increasing susceptibility to bacterial colonisation and transepidermal water loss. A pH-balanced cleanser maintains the acid mantle while delivering its active benefits.

D-Panthenol, included as a humectant and barrier-supporting ingredient, counterbalances the potential drying effect of salicylic acid, making the formulation more tolerable for daily use across all skin types.

← Back to Articles
MELASMA

Melasma in Indian Skin: Why Standard Protocols Fail

Melasma is the single most common pigmentary disorder presenting in Indian dermatology OPDs. Yet it remains one of the most poorly managed. Why? Because most treatment approaches address only one part of the problem.

Melasma is a multifactorial condition. UV radiation, hormonal triggers, heat, inflammation, and genetic predisposition all contribute. A complete protocol must address all three pillars simultaneously: photoprotection, active depigmentation, and systemic support where indicated.

Photoprotection is non-negotiable. Indian skin faces year-round UV exposure across UVB and UVA spectra. A sunscreen with minimum SPF 50+ and PA++++ rating must be the foundation of every melasma protocol.

Topical depigmentation should target melanin synthesis at multiple steps. A combination topical addressing multiple pathways delivers superior results over monotherapy. Systemic adjuvants such as Tranexamic Acid add a meaningful additional layer of treatment in refractory cases.

← Back to Articles
PHOTOPROTECTION

Why Sunscreen Compliance Fails in Indian Patients

Every dermatologist knows the pattern. You prescribe a complete melasma protocol. The patient returns three months later with full relapse. When asked about sunscreen, the answer is almost always the same: it felt too heavy, it left a white cast, or it was discontinued after a few weeks.

The most common reason for non-compliance in Indian skin types is cosmetic elegance. Indian patients, particularly those with Fitzpatrick types III–V, are highly sensitive to the sensory profile of a sunscreen. A greasy or white-cast formula will be abandoned within weeks regardless of its SPF rating.

The prescription choice matters significantly. A dermatologist-recommended sunscreen carries far greater compliance than one self-selected at a pharmacy. When dermatologists prescribe a specific, named product with clear instructions, compliance improves measurably.

GET IN TOUCH

Contact Arionix
Laboratories

We welcome feedback, suggestions, and professional enquiries from dermatologists, healthcare professionals, and trade partners.

Send Us
a Message

Reach Us
Directly

Registered Office
Arionix Laboratories
A Division of Aradhana Pharmaceuticals
The Roselia, 06 GF, Sector 95A
Gurugram — 122505, Haryana, India
Customer Care